Evaluation of the concentration-time curve of the a Crostin in healthy people.
Conditions
Interventions
Administration of one crocin tablet made by Samisaz company containing 15 mg of crocin orally..
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patient willingness to participate in the study Age above 18 years No addiction to narcotics, sedatives and alcohol No history of mental illness, no use of anticoagulants Absence of diabetes Absence of underlying disease
Exclusion criteria
Exclusion criteria: Hemodynamic instability in participant history of Cardiopulmonary resuscitation in participant past medical history of admission in the intensive care unit abnormal liver tests ( AST? ALT? CBC ) abnormal kidney tests ( U/A? BUN? Cr )
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of crostin blood concentration. Timepoint: Blood sampling will be done at 0, 30, 60, 90, 120, 180 and 240 minutes after drug administration. Method of measurement: Determination of crostin blood concentration by HPLC (High-performance liquid chromatography) system. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarzin Hadizadeh
Mashhad University of Medical Sciences
Outcome results
None listed